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Abstract
Introduction: Vascuologenesis is the de novo establishment of blood vessels and vascular networks from
mesoderm-derived endothelial cell precursors (angioblasts). Recently a novel mechanism, by which some
genetically deregulated and aggressive tumour cells generate “micro-vascular” channels without the participation of
endothelial cells and independent of angiogenesis, has been proposed. This has been termed “vasculogenic
mimicry” and has implications beyond angiogenesis and adds another layer of complexity to the current concept
for the generation of tumour micro-circulation. We suggest this is common phenomenon in head and neck
squamous cell carcinoma (HNSCC) cell lines and other aggressive tumour cell lines. We present experimental
evidence of vasculogenic mimicry in HNSCC cell lines and compare them with other tumours and a positive
control vascular cell line.
Materials and methods: The cell lines used were HUVEC, HN 2a, 2b (primary and metastatic tongue base
squamous carcinoma cell line), HCT116 (colonic carcinoma cell line) and DU145 (prostate carcinoma cell line).
Pilot experiments were undertaken to assess growth of a bank of tumour cell lines on (growth factor reduced)
matrigel (Sigma) with standard media (DMEM with 10% Fetal Calf Serum).
A functional growth assay was performed by preparing the appropriate cell suspension in serum free medium
plated onto either bare plastic or a well pre-coated with growth factor reduced type 4 collagen analogues.
Phase contrast photomicrographs were taken at 4 hours and 24 hours. Image analysis was performed; particular
features of interest were two dimensional area (surrogate of growth and migration), branch points and end point
measurements (surrogate of intercellular complexity).
Results: There were observable differences in growth of the cells on laboratory plastic and collagen matrix.
Tumour cells formed capillary like networks similar to HUVEC cells. Metastatic HNSCC cells lines were found to have
vasculogenic properties similar to HUVEC cell lines when compared to cell lines from their corresponding primary
tumour. The endothelial growth factor antibodies used did not inhibit or stimulate cell growth when compared to
control but did discourage vascular mimicry. Other tumour cell lines also displayed this property.
Discussion: Tumour “vasculogenic mimicry” must still be regarded as a controversial issue whose existence is not
proven. The clinical importance of this phenomenon however, is that it does explain the lack of complete efficacy
of current anti-angiogenic treatments due to the added layer of complexity. It provides a feasible mechanism of
early tumour vascular supply which can co-exist and incorporate with later angiogenic mechanisms. We suggest
that “vasculogenic mimicry” maybe a common neoplastic phenomena which appears to also be dictated by the
cells micro-environment. Its existence also suggests a further process that of the development of tumour mosaic
vessels as the neo-vasculature integrates with the existing endothelial lined systems.
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Introduction
The growth of solid tumours is limited to the distance
that oxygen, nutrients and waste products can diffuse
(1-2 mm), thus malignancy tends to remain dormant at
the size of 2-3 mm3 in the absence of neo-vascularisa-
tion. Much attention has been focussed on the role of
angiogenesis, i.e. the recruitment or co-option of new
vessels into a tumour from pre-existing vessels such as
capillaries and post-capillary venules. Currently, angio-
gensis is widely accepted as the mechanism by which
tumours metastasize, however angiogenesis may not be
the only mechanism by which tumours acquire a micro-
circulation. Maniotis et al. reported a novel mechanism
by which some aggressive tumours acquire a blood sup-
ply and demonstrated the generation of micro-vascular
channels by genetically deregulated and aggressive
tumour cells without the participation of endothelial
cells and independent of angiogenesis. This has been
termed “vasculogenic mimicry” and has implications
beyond angiogenesis and adds another layer of complex-
ity to the current theoretical framework for the genera-
tion of tumour micro-circulation [1].
Vascuologenesis hence is the de novo establishment of
blood vessels and vascular networks from mesoderm-
derived endothelial cell precursors (angioblasts). In con-
trast, the expansion of the vasculature by angiogenesis is
dependent on the generation of additional endothelial
cells from pre-existing vascular beds, i.e. it is the source
of the newly generated vascular lining or “endothelial
cells” that distinguishes vasculogenesis from angiogen-
esis. There is no doubt that there is an overlap of media-
tors and signalling systems in these two systems but their
roles may differ. Tumour cell plasticity is demonstrated
by the ability of tumour cells to adopt a variety of pheno-
types, including an endothelial phenotype [2,3] to allow
survival. These findings emphasize the plasticity of malig-
nant cells from advanced tumour progression stages, and
they require more dynamic view of the metastatic
cascade.
We need to understand how the malignant cells exert
cooperation from the normal cells. It is hypothesized that
both normal and malignant cells utilize the same molecules
for invasion, but that differences in downstream signalling
events allow the tumour cells to dominate over normal
cells in the microenvironment. This “dominant plasticity”
model of cancer metastasis takes into account the flexible
response of malignant cells to micro-environmental
pressures while maintaining dominance over the normal
parenchymal and stromal cells.
Vasculogenic mimicry has now been described in a
variety of tumours, i.e. ovarian and breast cancers, and
choroidal Melanomas [2-4]. We hypothesize that vascu-
logenic mimicry is a common neoplastic phenomenon
which appears to also be dictated by the cell’s micro-
environment (cell cytoskeletal interactions). Its existence
also suggests a further process that of the development
of tumour mosaic vessels as the neo-vasculature inte-
grates with the existing endothelial lined systems. We
present evidence of vasculogenic mimicry in head and
neck cancer cell lines and compare them with other
tumours and a positive control vascular cell line.
Materials and methods
The cell lines used were HUVEC, HN 2a, 2b (primary
and metastatic tongue base squamous carcinoma cell
line), HCT116 (colonic carcinoma cell line) and DU145
(prostate carcinoma cell line). Cells were grown in cul-
ture flasks (Costar 75 cm2 Vent Cap) in their appropri-
ate growth media (DMEM with 10% Fetal Calf Serum,
5% CO2). Cells were grown to 75% confluence and
serum starved for 24 to 48 hours before use. Experi-
ments were carried out using the appropriate serum free
medium for each cell line. Mycoplasma PCR assays were
carried out to exclude infection.
Pilot experiments were undertaken to assess growth of
a bank of tumour cell lines on (growth factor reduced)
matrigel (Sigma) with standard media (DMEM with 10%
Fetal Calf Serum). The cells were incubated at 37°C with
5% CO2. Phase contrast photomicrographs (Olympus sys-
tems) were taken at 4 hours and 24 hours. Image analysis
was performed by using Image Pro Plus 4.0 computer
image analysis software, particular features of interest
were two dimensional area (surrogate of growth and
migration), branch points and end point measurements
(surrogate of intercellular complexity), (Figure 1).
A modified growth assay was undertaken whereby cells
were grown to 75% confluence and plated directly upon a
96 well plate at a seeding density of 2*103 cells per well,
and serum starved for 24 hours. The cells were then
grown in serial dilutions of either pure antibody mixture
or blood product or a combination for a further 48
hours. 100 μl of alkaline phosphates substrate (3 mg/ml)
was then added to each well, incubated for 2 hours after
which 50 μl of 1 M NaOH was added and the plate
placed in a micro-plate reader and read at 405 nm
wavelength.
A functional growth assay was performed by preparing
the appropriate cell suspension in serum free medium
plated onto either bare plastic or a well pre-coated with
growth factor reduced matrigel [200 ul of matrigel per
well (incubated for 30 minutes)] at a seeding density of
2*105 cells per well. Where appropriate, cells were pre-
incubated for 1 hour with 10 ul of a mixture of 100 ul
of each anti-receptor (anti-FLK1, anti-FLT1, anti-FLT4)
and anti-ligand antibodies (anti-VEGFA, anti-VEGFC,
anti-VEGFD). The fresh media or antibody in fresh
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media was added to make a final volume of 900 ul and
the cells incubated for a further hour, after which a 100
ul of appropriate blood product (with or without anti-
body) was added. The cells were incubated at 37°C with
5% CO2. Phase contrast photomicrographs (Olympus
systems) were taken at 4 and 24 hours. Image analysis
was performed by using Image Pro Plus 4.0 computer
image analysis software, particular features of interest
were two dimensional area (which can be used as a sur-
rogate of growth and migration), branch points and end
point measurements (surrogate of intercellular complex-
ity, i.e. number of capillaries), (Figure 1). All results are
representative of at least two independent experiments
carried out in triplicate. Statistical analysis was per-
formed using Graph Pad Prism 4.0 software.
Results
There were observable differences in growth of the cells
on laboratory plastic and collagen matrix (P < 0.001),
(Figure 2). Tumour cells formed the appearance of
capillary-like networks similar to HUVEC cells (an
endothelial cell line).
Metastatic cell lines (HN2B) were found to have vascu-
logenic properties similar to HUVEC cell lines when
compared to cell lines from their corresponding primary
tumour (HN2A). The clinical impact of this phenomenon
will also be a function of tumour cell size enabling opti-
mal stromal interaction as evinced by the growth of other
tumour cell lines.
The anti-endothelial antibody was not cytotoxic to any
of the cell lines investigated. The antibody, however, did
discourage vascular mimicry significantly (P < 0.001). It
may be hypothesized that the visible networks may not
be tubes and not represent vascular channels but elec-
tron microscopy work suggests that they do [1].
Discussion
Tumour “vasculogenic mimicry” (Figure 3) must still be
regarded as a controversial issue whose existence is not
proven. The clinical importance of this phenomenon how-
ever, is that it does explain the lack of complete efficacy of
current anti-angiogenic treatments due to the added layer
of complexity. It provides a feasible mechanism of early
tumour vascular supply which can co-exist and incorpo-
rate with later angiogenic mechanisms. We suggest that
“vasculogenic mimicry” maybe a common neoplastic phe-
nomena (as seen in the tumour cells lines investigated)
which appears to also be dictated by the cells micro-envir-
onment (cell cytoskeletal interactions). Its existence also
suggests a further process that of the development of
tumour mosaic vessels as the neo-vasculature integrates
with the existing endothelial lined systems.
Figure 1 Morphological examination of cell lines by phase contrast micrographs at 24 hours. There appears an effect of substrate and
antibody on cell line growth patterns. The cell lines used were (1) Huvec cells on matrigel (X200); (2) Huvec cells on matrigel with antibody
(X200); (3) HN2a cells on plastic (X200); (4) HN2a cells on matrigel (X200); (5) HN2b cells on plastic (X200); (6) HN2b cells on matrigel (X200); (7)
HN2b cells on matrigel (X100); (8) HN2b cells on matrigel with antibody (X100); (9) HCT116 cells on matrigel (X200); (10) HCT116 cells on
matrigel with antibody (X200); (11) DU 145 cells on matrigel (X200); (12) DU145 cells on matrigel with antibody (X200).
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The process of angiogenesis consists of multiple,
sequential and independent steps with a vista of positive
and negative regulators of angiogenesis being involved
[5]. However, the mechanism by which an aggressive
tumour initially generates its own network of pseudo-vas-
cular channels challenges the assumption that angiogen-
esis and related mechanisms are the only means by
which a tumour acquires a blood supply [6]. Cell-cell
interactions and adhesion molecules: linking prolifera-
tion, survival, and motility should not be overlooked in
this cascade. The stromal microenvironment, in which
neoplastic cells develop, profoundly influences many
steps of cancer progression, including the ability of
tumor cells to metastasize. These influences of the
microenvironment are mediated, in large part, by bidirec-
tional interactions (adhesion, survival, proteolysis, migra-
tion, immune escape mechanisms lymph-/angiogenesis,
and homing on target organs) between epithelial tumour
cells and neighbouring stromal cells, i.e. fibroblasts as
well as endothelial and immune cells. Central to the
metastatic process, i.e. the changing adhesive preferences
of the cancer cells, from epithelial cells to fibroblasts and
endothelial cells, that dictate their reciprocal interactions
with the extracellular matrix (ECM) and neighbouring
stromal cells [7].
There is a consensus that the microcirculation of
aggressive tumours is complex, and depending on the
time of observation, could consist of mosaic vessels
(both tumour cells and endothelial cells), co-opted ves-
sels and/or angiogenic vessels. There is also strong evi-
dence for the existence of an intratumoral, tumour-cell-
lined, ECM-rich, patterned network that can provide an
extravascular fluid pathway, now known as the fluid-
conducting meshwork. The entire microcirculation in
aggressive tumours is suggested to be made up of a
combination of these elements, and it is the result of
destructive tumour growth and remodelling. Alterna-
tively, the PAS- and laminin-rich, fluid-conducting
meshwork could be an early survival mechanism for
nutrient exchange and the release of fluid pressure. This
meshwork could eventually be replaced by endothelial
cells from nearby angiogenic vessels or from the bone
marrow. The fluid-conducting meshwork might provide
a site for nutritional exchange for aggressive tumours,
and might therefore prevent necrosis of the tumour.
Alternatively, it might be analogous to an oedematous
inflammatory response, in which increased blood pres-
sure leads to the escape of fluid along connective tissue
pathways in intra-tissue spaces. The complex geometry
of the laminin-containing ECM covering that encases
the spheroidal clusters of tumour cells could also form a
suppressive shield against immune surveillance.
Endothelial cells can generate tractional forces, appro-
priate matrices, cord-like tessellated structures because
of a limited degree of cell-ECM attachment and a high
degree of cell-cell attachment [8]. The invasive cell gen-
erates channels consisting of a tubular network
embedded in the underlying substrate rather than a tes-
sellation raised above the monolayer. These aggressive
cells generate cords similar in appearance to endothe-
lium within the first few hours of culturing, forming
patterned tubes which are acellular and which resemble
the dimensions and patterning of networks in tumours.
Morphologically the substrate may be porous like a well.
So the cells fill the well then grow out or fall to spread
into another well. Hence the hexagonal type pattern
between sprouts. Perhaps the cells are constrained to
these shapes or patterns. This is not to say this situation
does not occur in nature on a type 4 collagen extracellu-
lar matrix bed. Substrate combination with antibodies
may reduce this spreading effect.
Endothelial cell shape requirements in the context of
growth and limited cell detachment typical of endothe-
lial cell differentiation may be mediated by the mechani-
cal properties of a continuous cytomatix, between the
Figure 2 Substrate directed growth of common tumour cell
lines on matrigel, a collagen basement membrane analogue,
resulted in significant growth and vascular channel formation
when compared to growth on standard laboratory culture
plastic, (P < 0.001). Furthermore the magnitude of this effect was
reduced by the use of specific anti-endothelial antibodies, (P <
0.001). Graph showing fold increase in growth area compared to
“standard” culture on laboratory Petri dishes. The Cell lines used
were HN2b (head and neck SCC), DU145 (Prostate cancer), HCT116
(Colonic cancer) and HUVEC (Human Endothelial cells).
Upile et al. Head & Neck Oncology 2011, 3:55
http://www.headandneckoncology.org/content/3/1/55
Page 4 of 7
Figure 3 Showing the hypothesis of “vasculogenic mimicry” in head and neck cell lines. The upper part of the image shows vascular
channel formation in a head and neck cell line. The lower part is a diagrammatic representation of a tumour lines blood vessel and its transition
to a mosaic lined vessel (containing tumour and co-opted “angiogenic sprouts” from host endothelial cells) joining a conventional endothelial
lined capillary of the systemic vasculature. This figure was adapted with permission and modified from: Folberg R, Hendrix MJ, Maniotis AJ.
Vasculogenic mimicry and tumor angiogenesis. Am J Pathol. 2000 Feb;156(2):361-81.
Upile et al. Head & Neck Oncology 2011, 3:55
http://www.headandneckoncology.org/content/3/1/55
Page 5 of 7
endothelial cell adhesion receptors and its nucleus and
could determine the response of the cell to its changing
architectural environment via a hard wired signalling
mechanism. The extended ECM/cyto-matrix/nuclear
matrix as a unit of structure/function is evidenced by
comparable tubular structures formed in culture by
highly invasive, interconnected primary and metastatic
melanoma. These have similarities to cords or tessella-
tions generated by a variety of other cell types including
mammary epithelial cells on the appropriate substrate. It
is assumed that more invasive cells generate cords simi-
lar to endothelium within the first few hours of cultur-
ing; patterned tubes completely acellular resemble the
dimensions and patterning of networks in tumours [3,8].
Hence the continuous tumour-ECM interaction and
traction consequently could contribute to tumour remo-
delling, metastatic potential and vascuologenetically pat-
terned tumour derived vessels and tumours. The
observation of antibody-mediated inhibition of vascular
mimicry was an intriguing finding suggesting the possi-
ble role of the vascular endothelial factors (either para-
crine or autocrine) in tumour vascularisation and
entrenchment.
The patterns of microcirculatory vessels have been
shown to have a prognostic significance in melanomas
with those with the presence of loops and networks
doing worse [3,9,10]. However review of vascular pat-
terns formed by tumour cell-generated patterns micro-
circulations may exist in tumours from other tissues as
well. The angiogenic switch hence is defined by both
the tumour cells ability to turn host’s blood vessels at a
given nexus but also by some changes in aggressive
tumour cells that allow them to turn themselves into
vessels that could provide micro-circulation. Patterned
micro-circulation in culture composed of tubules of an
acellular extracellular matrix lined on the outside by
tumour cells. A tumour circulation not lined by
endothelial cells would play a physiological role in the
maintenance and growth of aggressive tumours [8].
Human breast epithelial tumour cells form a disorga-
nised mass undergoing phenotypic reversion to form
acini resembling normal breast. Reversion occurs simply
by manipulating their surface receptors in three dimen-
sional assays.
In criticism of our current study, the networks formed
by the cultured cells do resemble microvascular chan-
nels but, fall short of being the compelling evidence of
vascular mimicry published by Maniotis et al. [1] in
their investigation of ocular malignant melanomas,
studying the tumour cells both cultured in vitro and in
tumour tissue. Our future study will necessitate further
light, electron and immuno-histological microscopy of
head and neck tumour tissue to confirm the presence of
membrane bounded microvascular channels, lined by
tumour cells alone, without endothelial cells. Including
examination of the cultured cell networks for PAS
matrix or sinusoidal channels or by microinjection of
dyes to establish flow patterns.
The clinical implications are, however, that there is
still too little knowledge of how the many events are
coordinated and integrated by the cancer cell, with con-
spiratorial help by the stromal component of the host.
Before drug development can proceed with a legitimate
chance of success, significant gaps in basic knowledge
need to be filled. A tumour circulation not lined by
endothelial cells would play an important physiological
role in the maintenance and growth of aggressive
tumours. This is observed in breast epithelial tumour
cells which form disorganised masses which undergo
phenotypic reversion to form acini resembling normal
tissue. This reversion occurs simply by manipulating
their surface receptors in a 3D assay. This continuous
tumour extracellular matrix interaction and traction
could contribute to tumour remodelling, its metastatic
potential and vasculo-genetically patterned tumour
derived abnormal vessels. The tubular structures formed
in culture by highly invasive, interconnected primary
and metastatic melanoma has similarities to cords or
tessellation generated by a variety of other tumour cells
on the appropriate substrate. Such vasculogenic triggers
and their receptors could be the next target for refined
pharmacological interventions in the treatment of
metastasis, as important if not more than the recently
trialled anti-angiogenic drugs. The important difference
may be that they could be more specific and avoid the
bystander cross receptor cardiac problems attendant
with anti-angiogenic therapy.
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